Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that protect against severe disease and preferably drive herd immunity. Regulators in numerous countries have authorised or approved COVID-19 vaccines for human use, with more expected to be licensed in 2021. Yet hav...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Lancet
Autors principals: Wouters, Olivier J, Shadlen, Kenneth C, Salcher-Konrad, Maximilian, Pollard, Andrew J, Larson, Heidi J, Teerawattananon, Yot, Jit, Mark
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Ltd. 2021
Matèries:
Health Policy
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7906643/
https://ncbi.nlm.nih.gov/pubmed/33587887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(21)00306-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars